+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials



A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials



Diabetes, Obesity and Metabolism 20(Suppl. 1): 22-33



To review the evolution and advancement of GLP-1 receptor agonist (GLP-1RA) therapy, through the lens of randomised controlled trials, from differentiating characteristics, efficacy, safety, tolerability, and cardiovascular outcomes, to evidence gaps and next steps. Clinical review of published phase 3 or later RCT data studying efficacy, safety, and outcomes of approved GLP-1 RA therapies. Through a wealth of studies, including both placebo-controlled and active-controlled studies, GLP-1 RAs have demonstrated high glycemic efficacy and ability to facilitate weight loss, with minimal risk of hypoglycemia, potential to restore beta cell function, and evidence for improved cardiovascular outcomes in those at risk. Over a decade of clinical studies have established the unique contributions of GLP-1 RAs in the treatment of diabetes. Individual differences between the different GLP-1 RAs, in delivery, pharmacokinetic and clinical effects, exist, allowing for tailored approaches to clinical care. The strength of evidence generated through RCTs, both short-term and long-term studies, will continue to evolve and inform our current paradigms in diabetes care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049726334

Download citation: RISBibTeXText

PMID: 29364586

DOI: 10.1111/dom.13162


Related references

A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. Diabetes, Obesity and Metabolism 20: 22-33, 2018

Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials. Journal of Endocrinological Investigation 40(11): 1251-1258, 2017

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 344: D7771, 2012

Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials. International Journal of Clinical Practice 70(8): 649-656, 2017

Use of α 2 -Adrenergic Agonists to Improve Surgical Field Visibility in Endoscopy Sinus Surgery: A Systematic Review of Randomised Controlled Trials. Clinical Therapeutics 40(1): 136-149.E19, 2017

Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials. Bmc Pulmonary Medicine 4: 7, 2004

Increasing recruitment to randomised trials: a review of randomised controlled trials. Bmc Medical Research Methodology 6: 34, 2006

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 317(7173): 1624-1629, Dec 12, 1998

Safety and efficacy of thrombopoietin-receptor agonists in myelodysplastic syndromes: a systematic review and meta-analysis of randomized controlled trials. British Journal of Haematology 167(5): 626-638, 2015

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials. Medicina Clinica 145(12): 511-519, 2016

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials. Medicina Clinica 139(10): 421-429, 2013

The Effect of Perioperative E-Health Interventions on the Postoperative Course: A Systematic Review of Randomised and Non-Randomised Controlled Trials. Plos One 11(7): E0158612, 2017

A protocol for a systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials. Systematic Reviews 5(1): 131, 2018

A protocol for a systematic review of non-randomised evaluations of strategies to increase participant retention to randomised controlled trials. Systematic Reviews 7(1): 30, 2018

Psychosocial interventions in perimenopausal and postmenopausal women: a systematic review of randomised and non-randomised trials and non-controlled studies. Maturitas 77(2): 93-110, 2014